Table 3.
Platelet Reactivity Index (PRI) in the two groups during the 1-year study
| PRI (mean ± SD, %) | |||||
|---|---|---|---|---|---|
| 3 months | 6 months | 9 months | 12 months | P-value* | |
| after randomisation | |||||
| Control group | 68.4 ± 17.2 | 48.5 ± 13.2 | 51.6 ± 19.8 | 65.3 ± 17.2 | >0.05 | 
| VASP-guided group | 73.5 ± 12.7 | 32.3 ± 4.9 | 35.5 ± 6.7 | 29.8 ± 7.3 | 0.001 | 
| P-value# | 0.4 | 0.04 | <0.001 | 0.03 | <0.001 | 
VASP vasodilator-stimulated phosphoprotein
*comparison between 3, 6, 9, and 12 months
#comparison between the control group and VASP-guided group